News

A new study has produced evidence of the source of chronic pain in humans, revealing several new targets for pain treatment.

The use of digital breast tomosynthesis (DBT), also known as 3D mammography, may significantly reduce the number of women who undergo breast biopsy for a non-cancerous lesion following an abnormal mammogram, according to a new study published in the journal Radiology.

A drug delivery device is under development, which works by slowly releasing antibiotics directly into the patient's stomach. This would allow patients to switch from daily to monthly doses, reducing the burden of tuberculosis treatment.

Researchers have identified eight new gene mutations that may cause or contribute to idiopathic dilated cardiomyopathy, a form of heart disease not caused by known external influences, such as high blood pressure, obesity, smoking, or diseased coronary arteries.

How does the immune system respond to fungi on our skin? Researchers at the University of Zurich have demonstrated that the same immune cells that protect us against skin fungi also encourage the inflammatory symptoms of atopic dermatitis. An antibody therapy could alleviate this chronic inflammatory skin disease.

While a lot of research has been directed at developing continuous sensing technologies, less effort has been directed to understanding the physiology of biofluid secretion.

An absorbable, antibiotic-eluting envelope implanted when implanting cardiac devices like pacemakers and defibrillators can cut the rate of major infections by 40 percent.

A blood test for fibromyalgia would be a relief for millions of people living with the poorly-understood condition, which is characterized by many symptoms including chronic widespread pain, sleep problems, and fatigue.

Researchers studied the connection between chronic periodontitis and dementia. The researchers learned that people with chronic periodontitis had a 6 percent higher risk for dementia than did people without periodontitis.

Scientists inserted a gene for a green-light receptor into the eyes of blind mice and, a month later, they were navigating around obstacles as easily as mice with no vision problems. They were able to see motion, brightness changes over a thousandfold range and fine detail on an iPad sufficient to distinguish letters.